NCT00246701View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

256

Participants

Timeline

Start Date

November 1, 2005

Primary Completion Date

June 1, 2006

Study Completion Date

June 1, 2006

Conditions

Hypertriglyceridemia

Interventions

DRUG

Simvastatin

Simvastatin

DRUG

Simvastatin + Lovaza

Simvastatin + Lovaza (omega-3-acid ethyl esters)

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY